ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard

April 22, 2011

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003